76 related articles for article (PubMed ID: 3218962)
1. Different responsiveness of normal and leukemic hemopoietic cells to esorubicin.
Bagnara GP; Rocchi P; Zauli G; Vitale L; Licia G; Damiano R; Paolucci G
Anticancer Res; 1988; 8(6):1303-6. PubMed ID: 3218962
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effect of epirubicin on human normal and leukemic hemopoietic cells.
Bagnara GP; Rocchi P; Bonsi L; Valvassori L; Marini M; Prodi G
Anticancer Res; 1987; 7(6):1197-200. PubMed ID: 3481683
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
Somekh E; Douer D; Shaked N; Rubinstein E
J Pharmacol Exp Ther; 1989 Jan; 248(1):415-8. PubMed ID: 2913285
[TBL] [Abstract][Full Text] [Related]
4. Preferential growth inhibition of human leukemic versus normal myeloid colony-forming cells by 12-O-tetradecanoylphorbol-13-acetate.
Park CH
Exp Hematol; 1984 Jun; 12(5):285-90. PubMed ID: 6723821
[TBL] [Abstract][Full Text] [Related]
5. Synergistic and antagonistic effects of recombinant human interleukin (IL) 3, IL-1 alpha, granulocyte and macrophage colony-stimulating factors (G-CSF and M-CSF) on the growth of GM-CSF-dependent leukemic cell lines.
Santoli D; Yang YC; Clark SC; Kreider BL; Caracciolo D; Rovera G
J Immunol; 1987 Nov; 139(10):3348-54. PubMed ID: 3500218
[TBL] [Abstract][Full Text] [Related]
6. Effect of thimerosal in leukemia, in leukemic cell lines, and on normal hematopoiesis.
Panella TJ; Huang AT
Cancer Res; 1990 Jul; 50(14):4429-35. PubMed ID: 2364396
[TBL] [Abstract][Full Text] [Related]
7. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
8. [The effect of the murine stromal cell line MS-5 on the proliferation and apoptosis of human erythromyeloid leukemic cell line K562].
Zaritskiĭ AIu; Konoplev SN; Konopleva MIu
Vopr Onkol; 1997; 43(3):304-8. PubMed ID: 9245087
[TBL] [Abstract][Full Text] [Related]
9. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells].
Zhong L; Jiang D; Wang Q
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):521-4. PubMed ID: 12080710
[TBL] [Abstract][Full Text] [Related]
12. STI571 and morpholine derivative of doxorubicin collaborate in inhibition of K562 cell proliferation by inducing differentiation and mitochondrial pathway of apoptosis.
Jakubowska J; Wasowska-Lukawska M; Czyz M
Eur J Pharmacol; 2008 Oct; 596(1-3):41-9. PubMed ID: 18782571
[TBL] [Abstract][Full Text] [Related]
13. Effect of direct cell-to-cell interaction between the KM-102 clonal human marrow stromal cell line and the HL-60 myeloid leukemic cell line on the differentiation and proliferation of the HL-60 line.
Ohkawa H; Harigaya K
Cancer Res; 1987 Jun; 47(11):2879-82. PubMed ID: 3471319
[TBL] [Abstract][Full Text] [Related]
14. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
[TBL] [Abstract][Full Text] [Related]
15. Murine flt3 ligand protects M1 leukemic cells from LIF-induced differentiation and suppression of self-renewal.
Begley CG; Rasko JE; Curtis D; Takagi K; Metcalf D; Hilton D; Roberts B; Nicola NA; Rossner MT
Exp Hematol; 1996 Aug; 24(10):1247-57. PubMed ID: 8765501
[TBL] [Abstract][Full Text] [Related]
16. Growth suppression of human leukemic cells in vitro by L-ascorbic acid.
Park CH; Amare M; Savin MA; Hoogstraten B
Cancer Res; 1980 Apr; 40(4):1062-5. PubMed ID: 6928398
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandin E on the proliferation and differentiation of leukemic progenitor cells in acute nonlymphocytic leukemia.
Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
Int J Cell Cloning; 1983 Dec; 1(6):440-50. PubMed ID: 6584501
[TBL] [Abstract][Full Text] [Related]
18. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7.
Auffray I; Dubart A; Izac B; Vainchenker W; Coulombel L
Exp Hematol; 1994 May; 22(5):417-24. PubMed ID: 7513651
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.
Gambacorti-Passerini C; le Coutre P; Mologni L; Fanelli M; Bertazzoli C; Marchesi E; Di Nicola M; Biondi A; Corneo GM; Belotti D; Pogliani E; Lydon NB
Blood Cells Mol Dis; 1997 Dec; 23(3):380-94. PubMed ID: 9446752
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of doxorubicin metabolites to human marrow erythroid and myeloid progenitors in vitro.
Dessypris EN; Brenner DE; Hande KR
Cancer Treat Rep; 1986 Apr; 70(4):487-90. PubMed ID: 3698042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
